Measles/Mumps/Rubella (MMR) Live Vaccine 2nd dose

Informed Consent 3

As I have argued on the Measles/Mumps/Rubella (MMR) ‘booster’ webpage, it’s likely that most children will be immune after the first dose of effective live MMR vaccine.

However, mass populations of already immune children are being arbitrarily revaccinated with a second dose of the live MMR vaccine because a small proportion of children may not have responded to the first dose.  In other words, millions of children are being over-vaccinated with the second dose of live MMR vaccine.

See below hyperlinks to my ongoing correspondence to individuals accountable on this matter, challenging the arbitrary second dose of live MMR vaccine:

  • Letter to (former) Prime Minister Tony Abbott challenging compulsory revaccination of children with the second dose of measles, mumps and rubella live virus vaccine, i.e. as mandated by the Australian Federal Government. (4 August 2015)
  • Letter to Sylvia Mathews Burwell, Secretary of the US Department of Health and Human Services re the government mandated second dose of Merck Measles/Mumps/Rubella (MMR) live vaccine and the National Vaccine Injury Compensation Program Authorizing Legislation Sec. 300aa-26  (7 January 2015)
  • Email to Steve Hambleton, President of the Australian Medical Association re the Measles/Mumps/Rubella (MMR) vaccine (second dose)  (2 May 2014)
  • Letter to Warwick Anderson, CEO of the National Health and Medical Research Council (NHMRC) re vaccination policy and practice in Australia  (15 April 2014)
  • Letter to Ian Olver, Chair of the NHMRC Australian Health Ethics Committee (AHEC) re Measles/Mumps/Rubella vaccination (second letter)  (12 April 2014)
  • Letter to Ian Olver, Chair of the NHMRC Australian Health Ethics Committee (AHEC) re the Australian Government’s requirement for revaccination of children with a second dose of live Measles/Mumps/Rubella (MMR) vaccine / lack of informed consent / adverse events  (19 March 2014)
  • Letter to Jonathan Temte, Chair of the US Advisory Committee on Immunization Practices (ACIP) re challenging mandated revaccination of children with the Measles/Mumps/Rubella (MMR) vaccine ‘booster’ second dose (5 March 2014)
  • Letter to Paul Offit questioning the ethics of mandated vaccination of children with the Measles/Mumps/Rubella (MMR) ‘booster’ second dose  (6 September 2013)
  • Email to Terry Nolan, Chair of the Australian Technical Advisory Group on Immunisation (ATAGI) re query re second MMR vaccine dose  (11 March 2013)
  • Letter to Tanya Plibersek, Australian Federal Minister for Health re questions re the ethics of Australian Government mandated vaccination  (28 June 2012)

Note: Dr Vittorio Demicheli, first author on the Cochrane Intevention Review: Vaccines for measles , mumps and rubella in children[1] was copied for information on my letters to Paul OffitTerry Nolan and Tanya Plibersek.

I have also contacted other individuals on this matter, i.e.

  • Email to Barbara Loe Fisher, President of the US National Vaccine Information Center re Merck MMRII Vaccine and NVICP Authorizing Legislation Sec. 300aa-26 Vaccine Information  (16 January 2015)
  • Email to Peter Mansfield, Visiting Research Fellow in the Discipline of General Practice University of Adelaide, and Director of Healthy Skepticism Inc re email to the President of the AMA re the Measles/Mumps/Rubella (MMR) vaccine (second dose)  (13 May 2014)
  • Emails to Peter Mansfield, Visiting Research Fellow in the Discipline of General Practice University of Adelaide, and Director of Healthy Skepticism Inc re vaccination/immunisation – live MMR vaccine second dose  (2 May 2014 and 22 April 2014)
  • Email to Philippa Dolan, Ashfords Solicitors UK re the court case involving two girls ordered to receive MMR vaccination  (14 November 2013)
  • Email to Barbara Loe Fisher, President of the US National Vaccine Information Center re vaccination, e.g. Paul Offit and the MMR ‘booster’  (11 September 2013)

 

[1] Demicheli V, Rivetti A, Debalini MG, Di Pietrantonj C. Vaccines for measles, mumps and rubella in children. Cochrane Database of Systematic Reviews 2012, Issue 2. Art. No.: CD004407. DOI: 10.1002/14651858.CD004407.pub3:http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004407.pub3/abstract